Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies

Abdul Rahman Hayati, Cheah Fook Choe, Ay Eeng Tan, Geok Chin Tan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Septal hypertrophic cardiomyopathy (sHCM) is a characteristic anomaly of the infant of diabetic mother (IDM). Insulin-like growth factor-1 (IGF-1) has been identified as a mediator of tissue overgrowth and we have previously shown that maternal IGF-1 levels were significantly elevated among neonates with asymmetrical sHCM. IGF-1 does not cross the placenta; it exerts physiologic action through binding to the IGF-1 receptor (IGF-1R). Localisation and expression of IGF-1R in term diabetic pregnancies are largely unclear. We have studied IGF-1R in the placentae of diabetic and normal pregnancies and this receptor expression in association with neonates with sHCM. Methods: IGF-1R localization and expression in the placentae of six diabetic pregnancies associated with neonatal sHCM were compared with six each of randomly selected diabetic and normal pregnancies without neonatal sHCM by immunohistochemistry. The staining for IGF-1R in the deciduas, cytotrophoblasts, syncytiotrophoblasts and villous endothelium for these 18 samples were assessed and scored by two pathologists who were blinded to the respective diagnoses. Results: Placental IGF-1R staining was negative in the villous endothelium for all three groups. IGF-1R staining was present in deciduas, cytotrophoblasts and syncytiotrophoblasts but the staining was weaker in the entire group of infants with sHCM compared to those without sHCM. Conclusions: IGF-1R is localized in all cell types of the placenta except in villous endothelium. Weaker placental IGF-1R staining in the placentae of diabetic pregnancies associated with sHCM suggests reduced expression of IGF-1R. This may be a down-regulatory response to elevated maternal IGF with neonatal sHCM outcome.

Original languageEnglish
Pages (from-to)41-46
Number of pages6
JournalEarly Human Development
Volume83
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Somatomedin Receptors
IGF Type 1 Receptor
Hypertrophic Cardiomyopathy
Placenta
Pregnancy
Trophoblasts
Somatomedins
Staining and Labeling
Endothelium
Pregnancy in Diabetics
Mothers
Newborn Infant
Negative Staining
Immunohistochemistry

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies. / Hayati, Abdul Rahman; Fook Choe, Cheah; Tan, Ay Eeng; Tan, Geok Chin.

In: Early Human Development, Vol. 83, No. 1, 01.2007, p. 41-46.

Research output: Contribution to journalArticle

@article{e0f10cf549624cdc84d6243ed697303c,
title = "Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies",
abstract = "Background: Septal hypertrophic cardiomyopathy (sHCM) is a characteristic anomaly of the infant of diabetic mother (IDM). Insulin-like growth factor-1 (IGF-1) has been identified as a mediator of tissue overgrowth and we have previously shown that maternal IGF-1 levels were significantly elevated among neonates with asymmetrical sHCM. IGF-1 does not cross the placenta; it exerts physiologic action through binding to the IGF-1 receptor (IGF-1R). Localisation and expression of IGF-1R in term diabetic pregnancies are largely unclear. We have studied IGF-1R in the placentae of diabetic and normal pregnancies and this receptor expression in association with neonates with sHCM. Methods: IGF-1R localization and expression in the placentae of six diabetic pregnancies associated with neonatal sHCM were compared with six each of randomly selected diabetic and normal pregnancies without neonatal sHCM by immunohistochemistry. The staining for IGF-1R in the deciduas, cytotrophoblasts, syncytiotrophoblasts and villous endothelium for these 18 samples were assessed and scored by two pathologists who were blinded to the respective diagnoses. Results: Placental IGF-1R staining was negative in the villous endothelium for all three groups. IGF-1R staining was present in deciduas, cytotrophoblasts and syncytiotrophoblasts but the staining was weaker in the entire group of infants with sHCM compared to those without sHCM. Conclusions: IGF-1R is localized in all cell types of the placenta except in villous endothelium. Weaker placental IGF-1R staining in the placentae of diabetic pregnancies associated with sHCM suggests reduced expression of IGF-1R. This may be a down-regulatory response to elevated maternal IGF with neonatal sHCM outcome.",
author = "Hayati, {Abdul Rahman} and {Fook Choe}, Cheah and Tan, {Ay Eeng} and Tan, {Geok Chin}",
year = "2007",
month = "1",
doi = "10.1016/j.earlhumdev.2006.04.002",
language = "English",
volume = "83",
pages = "41--46",
journal = "Early Human Development",
issn = "0378-3782",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies

AU - Hayati, Abdul Rahman

AU - Fook Choe, Cheah

AU - Tan, Ay Eeng

AU - Tan, Geok Chin

PY - 2007/1

Y1 - 2007/1

N2 - Background: Septal hypertrophic cardiomyopathy (sHCM) is a characteristic anomaly of the infant of diabetic mother (IDM). Insulin-like growth factor-1 (IGF-1) has been identified as a mediator of tissue overgrowth and we have previously shown that maternal IGF-1 levels were significantly elevated among neonates with asymmetrical sHCM. IGF-1 does not cross the placenta; it exerts physiologic action through binding to the IGF-1 receptor (IGF-1R). Localisation and expression of IGF-1R in term diabetic pregnancies are largely unclear. We have studied IGF-1R in the placentae of diabetic and normal pregnancies and this receptor expression in association with neonates with sHCM. Methods: IGF-1R localization and expression in the placentae of six diabetic pregnancies associated with neonatal sHCM were compared with six each of randomly selected diabetic and normal pregnancies without neonatal sHCM by immunohistochemistry. The staining for IGF-1R in the deciduas, cytotrophoblasts, syncytiotrophoblasts and villous endothelium for these 18 samples were assessed and scored by two pathologists who were blinded to the respective diagnoses. Results: Placental IGF-1R staining was negative in the villous endothelium for all three groups. IGF-1R staining was present in deciduas, cytotrophoblasts and syncytiotrophoblasts but the staining was weaker in the entire group of infants with sHCM compared to those without sHCM. Conclusions: IGF-1R is localized in all cell types of the placenta except in villous endothelium. Weaker placental IGF-1R staining in the placentae of diabetic pregnancies associated with sHCM suggests reduced expression of IGF-1R. This may be a down-regulatory response to elevated maternal IGF with neonatal sHCM outcome.

AB - Background: Septal hypertrophic cardiomyopathy (sHCM) is a characteristic anomaly of the infant of diabetic mother (IDM). Insulin-like growth factor-1 (IGF-1) has been identified as a mediator of tissue overgrowth and we have previously shown that maternal IGF-1 levels were significantly elevated among neonates with asymmetrical sHCM. IGF-1 does not cross the placenta; it exerts physiologic action through binding to the IGF-1 receptor (IGF-1R). Localisation and expression of IGF-1R in term diabetic pregnancies are largely unclear. We have studied IGF-1R in the placentae of diabetic and normal pregnancies and this receptor expression in association with neonates with sHCM. Methods: IGF-1R localization and expression in the placentae of six diabetic pregnancies associated with neonatal sHCM were compared with six each of randomly selected diabetic and normal pregnancies without neonatal sHCM by immunohistochemistry. The staining for IGF-1R in the deciduas, cytotrophoblasts, syncytiotrophoblasts and villous endothelium for these 18 samples were assessed and scored by two pathologists who were blinded to the respective diagnoses. Results: Placental IGF-1R staining was negative in the villous endothelium for all three groups. IGF-1R staining was present in deciduas, cytotrophoblasts and syncytiotrophoblasts but the staining was weaker in the entire group of infants with sHCM compared to those without sHCM. Conclusions: IGF-1R is localized in all cell types of the placenta except in villous endothelium. Weaker placental IGF-1R staining in the placentae of diabetic pregnancies associated with sHCM suggests reduced expression of IGF-1R. This may be a down-regulatory response to elevated maternal IGF with neonatal sHCM outcome.

UR - http://www.scopus.com/inward/record.url?scp=33845953122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845953122&partnerID=8YFLogxK

U2 - 10.1016/j.earlhumdev.2006.04.002

DO - 10.1016/j.earlhumdev.2006.04.002

M3 - Article

C2 - 16750336

AN - SCOPUS:33845953122

VL - 83

SP - 41

EP - 46

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - 1

ER -